New evidence shows Omniscan, optimark and Magnevist can cuause NSF more frequently than other Gadolinium agents

A panel of medical experts has found that several gadolinium contrast dyes – OptiMark, Omniscan and Magnevist – appear to carry more risk of nephrogenic systemic fibrosis (NSF) than others currently on the market. The advisory panel met yesterday at the behest of the U.S. Food & Drug Administration (FDA) to discuss possible labeling changes for the gadolinium agents

.

Gadolinium contrast dyes are approved for use in MRI procedures, and are sometimes used off-label in MRA studies. A mountain of evidence indicates that NSF only affects people with severe kidney disease who have been exposed to gadolinium agents.

Advertisements
This entry was posted in 1. Bookmark the permalink.

3 thoughts on “New evidence shows Omniscan, optimark and Magnevist can cuause NSF more frequently than other Gadolinium agents

  1. Illustrating NSF with an MR reconstructed image acquired without the use of any contrast agent looks a little bit abusive to me.
    DTI contrast is based on Intra Voxel Incoherent Motion of water and does not require any contrast media injection.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s